Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
| 1497 | 2 | CISPLATIN//ISOLATED LIMB PERFUSION//IFOSFAMIDE | 7807 |
| 14440 | 1 | ETOPOSIDE//ETOPOSIDE PHOSPHATE//ORAL ETOPOSIDE | 800 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | ETOPOSIDE | authKW | 816652 | 25% | 10% | 203 |
| 2 | ETOPOSIDE PHOSPHATE | authKW | 387873 | 2% | 62% | 16 |
| 3 | ORAL ETOPOSIDE | authKW | 242401 | 3% | 31% | 20 |
| 4 | TENIPOSIDE | authKW | 167282 | 2% | 22% | 19 |
| 5 | NK611 | authKW | 118184 | 0% | 100% | 3 |
| 6 | HLTH SCI CLIN PHARM | address | 90041 | 1% | 57% | 4 |
| 7 | ROSWELL PK MEM MED | address | 88636 | 0% | 75% | 3 |
| 8 | DIMETHYLAMINOETOPOSIDE | authKW | 78789 | 0% | 100% | 2 |
| 9 | ETOPOSIDE DOSAGE | authKW | 78789 | 0% | 100% | 2 |
| 10 | PIPERINE ANALOGUE | authKW | 78789 | 0% | 100% | 2 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 11023 | 60% | 0% | 483 |
| 2 | Pharmacology & Pharmacy | 3571 | 40% | 0% | 316 |
| 3 | Hematology | 103 | 4% | 0% | 34 |
| 4 | Chemistry, Analytical | 72 | 6% | 0% | 45 |
| 5 | Toxicology | 60 | 3% | 0% | 27 |
| 6 | Medical Laboratory Technology | 55 | 2% | 0% | 13 |
| 7 | Biochemical Research Methods | 33 | 3% | 0% | 25 |
| 8 | Chemistry, Medicinal | 23 | 2% | 0% | 19 |
| 9 | Pediatrics | 16 | 3% | 0% | 21 |
| 10 | Transplantation | 13 | 1% | 0% | 10 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | HLTH SCI CLIN PHARM | 90041 | 1% | 57% | 4 |
| 2 | ROSWELL PK MEM MED | 88636 | 0% | 75% | 3 |
| 3 | PHARMACEUT 332 N LAUDERDALE | 70908 | 0% | 60% | 3 |
| 4 | PHARMACEUT EVALUAT 1 | 70902 | 1% | 30% | 6 |
| 5 | PEDIAT PHARMACOKINET THER EUT | 52996 | 2% | 11% | 12 |
| 6 | WOODMONT OFF 2 | 48480 | 1% | 31% | 4 |
| 7 | ALTERNAT ENERGIES ATOM ENERGY COMMISS CEA | 39395 | 0% | 100% | 1 |
| 8 | CLIN PHARMACOL TOXICOL BRANCHWOODMONT OFF | 39395 | 0% | 100% | 1 |
| 9 | CLIN TRIAL DESIGN ANALWOODMONT OFF 1 | 39395 | 0% | 100% | 1 |
| 10 | EPPLEY CANC CORE PHARMACOKINET | 39395 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 59134 | 13% | 1% | 106 |
| 2 | CANCER TREATMENT REPORTS | 9427 | 3% | 1% | 23 |
| 3 | SEMINARS IN ONCOLOGY | 5477 | 3% | 1% | 27 |
| 4 | JOURNAL OF CLINICAL ONCOLOGY | 5243 | 6% | 0% | 47 |
| 5 | ANTI-CANCER DRUGS | 3380 | 2% | 1% | 17 |
| 6 | CANCER TREATMENT REVIEWS | 3288 | 2% | 1% | 13 |
| 7 | EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY | 2994 | 2% | 1% | 12 |
| 8 | INVESTIGATIONAL NEW DRUGS | 2546 | 2% | 1% | 13 |
| 9 | CLINICAL PHARMACOKINETICS | 1607 | 1% | 0% | 10 |
| 10 | INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS | 1408 | 2% | 0% | 12 |
Author Key Words |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | ETOPOSIDE | 816652 | 25% | 10% | 203 | Search ETOPOSIDE | Search ETOPOSIDE |
| 2 | ETOPOSIDE PHOSPHATE | 387873 | 2% | 62% | 16 | Search ETOPOSIDE+PHOSPHATE | Search ETOPOSIDE+PHOSPHATE |
| 3 | ORAL ETOPOSIDE | 242401 | 3% | 31% | 20 | Search ORAL+ETOPOSIDE | Search ORAL+ETOPOSIDE |
| 4 | TENIPOSIDE | 167282 | 2% | 22% | 19 | Search TENIPOSIDE | Search TENIPOSIDE |
| 5 | NK611 | 118184 | 0% | 100% | 3 | Search NK611 | Search NK611 |
| 6 | DIMETHYLAMINOETOPOSIDE | 78789 | 0% | 100% | 2 | Search DIMETHYLAMINOETOPOSIDE | Search DIMETHYLAMINOETOPOSIDE |
| 7 | ETOPOSIDE DOSAGE | 78789 | 0% | 100% | 2 | Search ETOPOSIDE+DOSAGE | Search ETOPOSIDE+DOSAGE |
| 8 | PIPERINE ANALOGUE | 78789 | 0% | 100% | 2 | Search PIPERINE+ANALOGUE | Search PIPERINE+ANALOGUE |
| 9 | PREDICTION OF AUC AND C MAX | 78789 | 0% | 100% | 2 | Search PREDICTION+OF+AUC+AND+C+MAX | Search PREDICTION+OF+AUC+AND+C+MAX |
| 10 | SCHEDULE DEPENDENCY | 57926 | 1% | 29% | 5 | Search SCHEDULE+DEPENDENCY | Search SCHEDULE+DEPENDENCY |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |